Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2026-01-03 @ 6:38 AM
Study NCT ID:
NCT00475293
Status:
COMPLETED
Last Update Posted:
2013-09-13
First Post:
2007-05-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC
Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TTD-06-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |